Display options
Cite
Meilahn EN. Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women. J Thromb Thrombolysis. 1995;1(2):125-131doi: 10.1007/BF01062569.
Meilahn, E. N. (1995). Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women. Journal of thrombosis and thrombolysis, 1(2), 125-131. https://doi.org/10.1007/BF01062569
Meilahn. "Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women." Journal of thrombosis and thrombolysis vol. 1,2 (1995): 125-131. doi: https://doi.org/10.1007/BF01062569
Meilahn EN. Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women. J Thromb Thrombolysis. 1995;1(2):125-131. doi: 10.1007/BF01062569. PMID: 10603521.
Copy Download .nbib Format: NLM
Share it on

J Thromb Thrombolysis. 1995;1(2):125-131. doi: 10.1007/BF01062569.

Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women.

Journal of thrombosis and thrombolysis

Meilahn

Affiliations

  1. London School of Hygiene and Tropical Medicine, Department of Epidemiolgy and Population Studies.

PMID: 10603521 DOI: 10.1007/BF01062569

Abstract

The following is a review of (largely) epidemiologic evidence on whether changes in plasma hemostatic concentrations occur with menopause and with postmenopausal hormone therapy which may have an impact on risk of ischemic heart disease. To date, only plasma fibrinogen has been positively associated with long-term risk of disease among women; however, data are sparse. Taken together, the evidence supports an impact of endogenous sex hormone levels on thrombotic potential and points to a modest increase in a number of plasma hemostatic factor levels at menopause. Results of studies of estrogen therapy are somewhat conflicting. Observational findings suggest that, except for possibly the Factor VII level, estrogen therapy may prevent the menopause-related rise in plasma hemostatic factors. In contrast, controlled experiments have found increased markers of thrombin generation with use of common formulations of estrogen therapy. The hemostatic effects found with oral preparations do not appear to occur with transdermal forms of estrogen although data are limited. Overall, the evidence shows menopause to have an impact on plasma levels of hemostatic factors which appears to be modified by use of oral estrogen. Whether these alterations in plasma levels have an impact on risk of ischemic heart disease among postmenopausal women remains to be demonstrated.

References

  1. Arterioscler Thromb. 1994 Jun;14(6):862-8 - PubMed
  2. Ann Intern Med. 1992 Dec 15;117(12):1016-37 - PubMed
  3. Br Med J. 1977 Apr 9;1(6066):935-6 - PubMed
  4. N Engl J Med. 1986 Jun 19;314(25):1615-20 - PubMed
  5. Thromb Haemost. 1982 Apr 30;47(2):157-61 - PubMed
  6. Eur Heart J. 1989 Jan;10(1):77-82 - PubMed
  7. Ann Intern Med. 1993 Jun 15;118(12):956-63 - PubMed
  8. Am J Med. 1992 Mar;92(3):275-82 - PubMed
  9. Br Heart J. 1986 Jan;55(1):58-66 - PubMed
  10. Arterioscler Thromb. 1993 Dec;13(12 ):1829-36 - PubMed
  11. Int J Epidemiol. 1990 Mar;19(1):42-8 - PubMed
  12. Circulation. 1993 Oct;88(4 Pt 1):1999-2009 - PubMed
  13. Acta Obstet Gynecol Scand. 1993 Aug;72(6):423-7 - PubMed
  14. Lancet. 1986 Sep 6;2(8506):533-7 - PubMed
  15. Maturitas. 1993 Jul;17(1):17-22 - PubMed
  16. J Clin Epidemiol. 1989;42(8):719-23 - PubMed
  17. Thromb Res. 1990 Jan 15;57(2):227-34 - PubMed
  18. Am J Epidemiol. 1990 Jul;132(1):41-6 - PubMed
  19. J Biol Chem. 1983 Apr 10;258(7):4599-605 - PubMed
  20. J Lab Clin Med. 1988 Jan;111(1):52-6 - PubMed
  21. Obstet Gynecol. 1984 May;63(5):621-5 - PubMed
  22. Am J Obstet Gynecol. 1961 Dec;82:1211-5 - PubMed
  23. Thromb Haemost. 1995 Apr;73(4):623-5 - PubMed
  24. JAMA. 1991 Jul 24-31;266(4):521-7 - PubMed
  25. Br J Haematol. 1990 Jan;74(1):77-81 - PubMed
  26. Arterioscler Thromb. 1993 Feb;13(2):162-9 - PubMed
  27. Hum Reprod. 1991 Aug;6(7):925-7 - PubMed
  28. Br J Haematol. 1984 Feb;56(2):233-41 - PubMed
  29. J Lab Clin Med. 1988 Feb;111(2):224-8 - PubMed
  30. Int J Epidemiol. 1989 Jun;18(2):361-7 - PubMed
  31. Thromb Haemost. 1985 Aug 30;54(2):475-9 - PubMed
  32. Lancet. 1991 Oct 26;338(8774):1079 - PubMed
  33. Am Heart J. 1987 Aug;114(2):413-9 - PubMed
  34. Br Med J. 1979 Jan 20;1(6157):153-6 - PubMed
  35. N Engl J Med. 1989 Sep 7;321(10):641-6 - PubMed
  36. Thromb Haemost. 1993 Oct 18;70(4):584-7 - PubMed
  37. Am J Epidemiol. 1994 Jun 15;139(12):1164-79 - PubMed
  38. Lancet. 1977 Jun 25;1(8026):1354-5 - PubMed
  39. Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):396-403 - PubMed
  40. Br J Haematol. 1993 Apr;83(4):616-21 - PubMed
  41. Am J Obstet Gynecol. 1981 Sep 15;141(2):149-52 - PubMed
  42. Am J Obstet Gynecol. 1993 Dec;169(6):1549-53 - PubMed
  43. Thromb Res. 1978 Aug;13(2):279-83 - PubMed
  44. Arterioscler Thromb. 1992 Sep;12(9):1063-70 - PubMed
  45. Br J Obstet Gynaecol. 1992 May;99(5):439-40 - PubMed
  46. Am J Clin Nutr. 1992 May;55(5):950-4 - PubMed
  47. Maturitas. 1993 Dec;18(1):55-64 - PubMed
  48. Thromb Res. 1990 Jun 15;58(6):645-51 - PubMed
  49. Br Med Bull. 1992 Apr;48(2):276-308 - PubMed
  50. Prostaglandins. 1990 Jan;39(1):33-7 - PubMed
  51. Br Med J. 1975 Oct 18;4(5989):139-43 - PubMed
  52. N Engl J Med. 1987 Apr 30;316(18):1105-10 - PubMed
  53. Br J Obstet Gynaecol. 1990 Oct;97(10):939-44 - PubMed
  54. Ann Epidemiol. 1992 Jul;2(4):471-80 - PubMed
  55. Ann N Y Acad Sci. 1990;592:193-203; discussion 257-62 - PubMed
  56. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 2):1042-8 - PubMed
  57. BMJ. 1992 Sep 5;305(6853):567-74 - PubMed
  58. Lancet. 1983 Jan 1;1(8314-5):22-4 - PubMed
  59. Ann Epidemiol. 1992 Jul;2(4):445-55 - PubMed
  60. Ann Intern Med. 1978 Aug;89(2):157-61 - PubMed
  61. Thromb Haemost. 1992 Oct 5;68(4):392-5 - PubMed
  62. BMJ. 1989 Mar 11;298(6674):642-4 - PubMed

Publication Types